SOLTF
Price
$6.60
Change
+$0.80 (+13.79%)
Updated
Jun 26 closing price
Capitalization
544.22M
XTLB
Price
$1.32
Change
+$0.12 (+10.00%)
Updated
Jul 3 closing price
Capitalization
11.57M
Interact to see
Advertisement

SOLTF vs XTLB

Header iconSOLTF vs XTLB Comparison
Open Charts SOLTF vs XTLBBanner chart's image
Nxera Pharma
Price$6.60
Change+$0.80 (+13.79%)
Volume$1.5K
Capitalization544.22M
XTL Biopharmaceuticals
Price$1.32
Change+$0.12 (+10.00%)
Volume$43.81K
Capitalization11.57M
SOLTF vs XTLB Comparison Chart in %
Loading...
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTLB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SOLTF vs. XTLB commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SOLTF is a Hold and XTLB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 07, 2025
Stock price -- (SOLTF: $6.60 vs. XTLB: $1.32)
Brand notoriety: SOLTF and XTLB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SOLTF: 294% vs. XTLB: 107%
Market capitalization -- SOLTF: $544.22M vs. XTLB: $11.57M
SOLTF [@Biotechnology] is valued at $544.22M. XTLB’s [@Biotechnology] market capitalization is $11.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.35B to $0. The average market capitalization across the [@Biotechnology] industry is $2.39B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SOLTF’s FA Score shows that 0 FA rating(s) are green whileXTLB’s FA Score has 0 green FA rating(s).

  • SOLTF’s FA Score: 0 green, 5 red.
  • XTLB’s FA Score: 0 green, 5 red.
According to our system of comparison, XTLB is a better buy in the long-term than SOLTF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SOLTF’s TA Score shows that 6 TA indicator(s) are bullish while XTLB’s TA Score has 6 bullish TA indicator(s).

  • SOLTF’s TA Score: 6 bullish, 2 bearish.
  • XTLB’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, XTLB is a better buy in the short-term than SOLTF.

Price Growth

SOLTF (@Biotechnology) experienced а 0.00% price change this week, while XTLB (@Biotechnology) price change was +11.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.30%. For the same industry, the average monthly price growth was +17.40%, and the average quarterly price growth was -0.11%.

Industries' Descriptions

@Biotechnology (+6.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SOLTF($544M) has a higher market cap than XTLB($11.6M). SOLTF YTD gains are higher at: 7.186 vs. XTLB (-34.841).
SOLTFXTLBSOLTF / XTLB
Capitalization544M11.6M4,690%
EBITDAN/AN/A-
Gain YTD7.186-34.841-21%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/A133K-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SOLTF vs XTLB: Fundamental Ratings
SOLTF
XTLB
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
10097
SMR RATING
1..100
8798
PRICE GROWTH RATING
1..100
5363
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
3850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

XTLB's Valuation (43) in the Biotechnology industry is somewhat better than the same rating for SOLTF (85) in the null industry. This means that XTLB’s stock grew somewhat faster than SOLTF’s over the last 12 months.

XTLB's Profit vs Risk Rating (97) in the Biotechnology industry is in the same range as SOLTF (100) in the null industry. This means that XTLB’s stock grew similarly to SOLTF’s over the last 12 months.

SOLTF's SMR Rating (87) in the null industry is in the same range as XTLB (98) in the Biotechnology industry. This means that SOLTF’s stock grew similarly to XTLB’s over the last 12 months.

SOLTF's Price Growth Rating (53) in the null industry is in the same range as XTLB (63) in the Biotechnology industry. This means that SOLTF’s stock grew similarly to XTLB’s over the last 12 months.

SOLTF's P/E Growth Rating (100) in the null industry is in the same range as XTLB (100) in the Biotechnology industry. This means that SOLTF’s stock grew similarly to XTLB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SOLTFXTLB
RSI
ODDS (%)
Bullish Trend 4 days ago
33%
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
41%
Bullish Trend 4 days ago
76%
Momentum
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
48%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
33%
Bullish Trend 4 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
31%
Bullish Trend 4 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 10 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
63%
Bullish Trend 4 days ago
85%
Aroon
ODDS (%)
Bullish Trend 4 days ago
22%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SOLTF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XTLB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AEE96.020.54
+0.57%
Ameren Corp
MODG9.08-0.15
-1.63%
Topgolf Callaway Brands Corp
ECX2.16-0.04
-1.82%
ECARX Holdings
ACTU6.59-0.15
-2.23%
Actuate Therapeutics Inc
SNSE9.03-0.24
-2.54%
Sensei Biotherapeutics Inc

SOLTF and

Correlation & Price change

A.I.dvisor indicates that over the last year, SOLTF has been loosely correlated with BIESF. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLTF jumps, then BIESF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SOLTF
1D Price
Change %
SOLTF100%
N/A
BIESF - SOLTF
35%
Loosely correlated
N/A
XTLB - SOLTF
24%
Poorly correlated
+10.00%
SLRN - SOLTF
23%
Poorly correlated
N/A
SPHRF - SOLTF
22%
Poorly correlated
N/A
PRTG - SOLTF
20%
Poorly correlated
-3.08%
More

XTLB and

Correlation & Price change

A.I.dvisor indicates that over the last year, XTLB has been closely correlated with LABFF. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if XTLB jumps, then LABFF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XTLB
1D Price
Change %
XTLB100%
+10.00%
LABFF - XTLB
70%
Closely correlated
N/A
SER - XTLB
59%
Loosely correlated
-3.26%
ENTBF - XTLB
29%
Poorly correlated
N/A
UNCY - XTLB
28%
Poorly correlated
-0.86%
ANRO - XTLB
26%
Poorly correlated
+2.17%
More